tiprankstipranks

Bio-Techne price target lowered to $60 from $75 at Stifel

Stifel lowered the firm’s price target on Bio-Techne (TECH) to $60 from $75 and keeps a Hold rating on the shares. Growth is expected to step down to the low-single digit range in fiscal Q4, notes the analyst, who sees Bio-Techne as “somewhat caught between trying to lower expectations in a way that derisks the outlook while still signaling growth possibilities that can yield top-line differentiation.”

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue